Chapter 24: Disorders of White Blood Cells and Lymphoid Tissues

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome to the Deep Dive.

Today, we're really getting into the core of your body's defense system.

We're talking white blood cells, lymphoid tissues,

basically the immune frontline.

Exactly.

And it's all about balance.

Right.

And we're diving into what happens when that balance just completely breaks down, catastrophically fails, really.

Our mission today, basically, is to link the core pathophysiology concepts to, well, to main outcomes.

What happens when you don't have enough of these cells and what happens when they just multiply out of control?

That distinction is absolutely key.

You start with leukopenia.

That's the deficiency sign.

Your white blood cell counts are just too low.

Then you flip to the proliferative disorders.

That's where the cells expand.

Now, sometimes that expansion is normal,

reactive, like fighting off a virus.

Right.

Your body doing its job.

Exactly.

But the dangerous side is when it's neoplastic,

malignant.

We're talking cancer, leukemia, lymphoma.

And that's the core failure we want to unpack, the molecular switch.

That's it.

How a protector turns into an invader.

Okay, let's get into it.

So to really understand the chaos when it fails,

we need a quick map of the healthy system.

It all starts in the bone marrow, right?

The myeloid tissue.

That's the main production center.

Yes.

But the immune system itself kind of splits off early on.

Two major lines.

Two lines.

Think of it like this.

The myeloid line stays mostly in the bone marrow to develop.

It produces the rapid responders, your granulocytes like neutrophils and monocytes.

The foot soldiers, first on the scene.

Precisely.

They tackle immediate threats, especially bacteria.

Then you have the lymphoid stem cell line.

Okay.

These become the lymphocytes.

T -cells and B -cells are more strategic.

Long -term memory coordinating the big picture.

And this distinction matters for the types of cancer later.

Absolutely critical.

Which line fails determines whether you're looking at a myeloid leukemia or lymphocytic leukemia or lymphoma.

Totally different diseases.

Got it.

And these lymphoid cells, they don't all just stay in the marrow, do they?

No.

Maturation is key.

Yeah.

The lymphocytes mostly finish up in the bone marrow, but then they head out to lymph nodes and differentiate into plasma cells, the antibody factories.

Right.

And T -cells.

T -lymocytes are different.

They leave the marrow early and head to the thymus.

Like a boot camp.

Exactly.

So they're specialized training grout.

They mature into CD4 plus HEPRT T -cells, the generals orchestrating the whole response, and CD8 plus cytotoxic T -cells.

The assassins.

The direct killers, yeah.

Killing infected cells.

And what controls all this production?

It must be tightly regulated.

Oh, absolutely.

It's managed by chemical signals, cytokines, and growth factors.

Like interleukin -1, GMCSF.

It's a whole chemical language telling the marrow, make more neutrophils, or slow down on the lymphocytes.

So the lymph nodes fit in a staging area.

Like forward operating bases, yeah.

Bean -shaped structures scattered everywhere with lymphocytes gathered there.

And inside you have specific zones.

A cortex area, mainly for B -cells, these structures called follicles.

And a pair cortex for T -cells.

And you mentioned follicles, primary and secondary.

Right.

Primary are inactive, secondary follicles are active.

They have germinal centers where B -cells are really buzzing.

And that activity, that's significant.

Very significant.

Because those active secondary follicles, that's often where lymphomas, the cancers of the lymph nodes, actually originate.

Where the rebellion starts.

Okay.

So moving from the normal setup to the problems.

Let's start with deficiency.

Leukopenia.

Right.

Technically, leukopenia is just a low total white blood cell count.

Maybe under 5 ,000 per microliter.

But clinically,

almost always the real problem is neutropenia.

Low neutrophils.

Those foot soldiers again.

Exactly.

A count below 1 ,000 per microliter is neutropenia.

If it drops way down below 500 for the absolute neutrophil count, or ANC, that's severe.

Very dangerous.

Why so dangerous?

Because neutrophils are your primary defense against bacteria.

Without them, even normal bacteria living on your skin or in your gut can cause a life -threatening systemic infection.

The risk is inversely proportional to that ANC.

So what causes neutropenia?

It can be congenital -borne with it.

Like Cosman syndrome, a severe form where neutrophil production just halts very early.

Kids with this have constant infections.

And the notes mention a higher leukemia risk too.

Disturbingly, about 20 % might develop acute myeloid leukemia later.

There's also cyclic neutropenia, where counts drop periodically.

Most cases are acquired, right?

Oh yes.

Most often, it's actually related to infections.

Especially viruses that can temporarily suppress the bone marrow.

Or drugs.

Definitely.

Cancer chemotherapy is a huge one.

It hits the bone marrow hard, suppressing production of all blood cells.

Autoimmune causes two antibodies attacking neutrophils.

What's fascinating, though, is how it presents clinically.

You mentioned a paradox.

Right.

This is crucial.

In severe neutropenia, the patient might have a raging fever,

chills clear signs of systemic infection.

But the usual local signs of inflammation, redness, swelling, pus at the infection site might be totally absent.

Because you need neutrophils to create pus and those visible signs.

Without them, the local battle doesn't look like much, even though the systemic infection is critical.

It makes diagnosis tricky.

That silence is deadly.

Wow.

Okay, so that's the damage from too few cells.

What about too many, but not cancer yet?

Like, uh, mono.

Oh.

Infectious mononucleosis.

Classic example of a self -limiting lymphoproliferative disorder.

It's benign, usually.

Caused by EBV.

85 % of the time, yes.

Epstein -Barr virus.

Spreads easily, usually through saliva, hence the kissing disease nickname.

And it affects B cells.

Exactly.

EBV infects B lymphocytes, triggers them to proliferate as part of the immune response, and then importantly, it stays latent into those B cells for your entire life.

What are the key symptoms we should look for?

After a four, six week incubation, you get this produral malaise, not feeling hungry.

Then the classic triad hits.

High fever, really sore throat, pharyngitis, and swollen lymph nodes everywhere.

Neck, armpits, groin.

And the spleen.

I remember hearing about spleen issues.

Yes, about 50 -60 % get enlarged spleen splenomegaly.

That proliferation is intense.

And that's why contact sports are a no -go.

Absolutely.

The risk of splenic rupture is low, less than half a percent.

But if it happens, it's a major emergency.

So no football during mono.

You can also get some hepatitis, but it usually resolves fine.

All right, now we turn the corner into the really serious stuff.

Malignant proliferation.

Lymphomas and leukemias.

The true cellular rebellion.

And a key feature here is that because blood cells travel everywhere, these cancers are often widespread or disseminated right from the start.

Unlike a solid tumor that might stay local for a while.

Exactly.

Let's start with lymphomas cancers originating in the lymphoid tissues, usually nodes.

Two big categories.

First, non -Hodgkin lymphomas or NHLs.

Okay.

NHLs.

What defines them?

Well, NHL is actually a huge diverse group.

B -cell types, T -cell types, even NK cell types.

But a key characteristic is they tend to be multi -centric.

Meaning?

They often arise in multiple lymph nodes or sites simultaneously.

And they spread early and unpredictably to the liver, spleen, bone marrow.

So much less predictable than, well, we'll get to the other type.

What are some examples of NHL?

You have types like follicular lymphoma, often derived from those germinal center B -cells we mentioned.

It's typically slow -growing, indolent.

Patients can live with it for years.

But there's a catch.

Big catch.

About a third of follicular lymphomas eventually transform into a much more aggressive type, usually diffuse large B -cell lymphoma or DLBCL.

And DLBCL is?

Aggressive.

Rapidly growing, rapidly fatal if it's not treated effectively.

It's actually the most common type of NHL in older adults.

Then there's Burkitt lymphoma.

Extremely aggressive.

One of the fastest growing human tumors.

Linked to EBV in certain parts of Africa.

How do these NHLs typically show up?

What do patients experience?

The indolent forms, like follicular, might just present as painless swollen lymph nodes that the person notices gradually.

But the aggressive forms, like DLBCL or transformed follicular, often come with those constitutional symptoms we need to recognize.

Right.

The B symptoms.

Exactly.

Unexplained fever,

drenching night sweats, soaking the bedsheets, and significant weight loss without trying.

That triad signals something serious, systemically wrong.

Plus, they often have poor antibody production, leading to infections.

Okay, so that's the diverse, often widespread NHLs.

What's the other big category?

The other one is Hodgkin lymphoma or HL.

It's distinct.

How so?

What makes it different?

It's defined by one specific, very weird looking cell.

The Reed -Sternberg cell.

Large, atypical, often has multiple nuclei.

Finding the cell under the microscope is the key diagnostic hallmark.

Even though it's rare in the tumor itself.

You said less than 1%.

That's right.

It's like finding the crucial clue.

We now know it's actually a B cell, specifically a post -germinal center B cell that's gone wrong.

But its presence is what defines HL.

And how does HL behave differently from NHL?

Very differently in terms of spread.

Unlike NHL's multicentric origin, HL usually starts in a single lymph node or single chain of nodes.

And then it spreads in a predictable, orderly fashion to adjacent contiguous lymph nodes.

Often starts above the diaphragm neck nodes, maybe a mass in the chest, mediastidum.

That predictability must make a huge difference for treatment.

Massive difference.

It's a major reason why HL has such a better prognosis, especially in early stages.

The source material mentions 5 -year survival rates around 95 % for early disease.

That's incredible compared to aggressive NHLs.

It really is.

Targeted radiation, effective chemotherapy.

It's often curable because you know where it's likely to be and go next.

Does HL have characteristic symptoms too?

Yes.

Painless node enlargement, often above the diaphragm is common.

And the classic systemic symptoms can include intense itching, pruritus, intermittent fevers, and those drenching night sweats again.

Does it impact the immune system overall?

It does, particularly as it progresses.

It tends to impair T -cell function, the cell -mediated immunity.

This leads to a state called energy where the T -cells don't respond properly.

Making patients vulnerable to?

The viruses, fungi, protozoa.

Infections that T -cells normally keep in check.

Okay, let's shift from lymphomas, which start in nodes, to the leukemias.

What's the defining feature there?

Leukemias are fundamentally cancers of the bone marrow itself.

The marrow gets diffusely replaced by unregulated, immature neoplastic cells.

We call these immature cells blasts.

Blasts.

So the factory is taken over by defective products.

That's a good way to put it.

And classification is pretty straightforward.

Based on the cell line involved lymphocytic, from the lymphoid line, or myelogenous, from the myeloid line.

Okay.

And then based on how fast it progresses,

acute, rapid onset, mostly blasts, or chronic, slower onset, more mature -looking cells involved.

Initially, at least.

And the root cause, like lymphomas, is genetic.

Almost always.

Genetic dysregulation is key.

Over -hass of leukemia cases show specific, recurring chromosomal abnormalities, translocations, deletions, inversions.

Like the famous one.

Ah, yes.

The Philadelphia chromosome, this is a textbook example, really shows the molecular basis.

What is it exactly?

It's a specific translocation, a swap of material, between chromosome 9 and chromosome 22, written as T922.

And that swap creates...

That's a new abnormal fusion gene called BCRABL.

BCRABL.

Right.

And the protein made from this fusion gene is the problem.

It's a hyperactive enzyme, a tyrosine kinase.

Meaning it signals constantly.

Constantly tells the cell to grow and divide.

Yeah, it completely bypasses the normal stop signals.

Yeah.

It's the engine driving the malignancy.

And this is linked to which leukemia?

It's the defining feature of chronic myelogenous leukemia, CML.

Found in over 90 % of CML patients.

Its discovery really paved the way for targeted therapies.

Okay, let's talk about the acute forms first.

All in AML, what's their story?

Acute lymphoblastic leukemia, ALL,

and acute myelogenous leukemia, AML.

The key word is acute, rapid onset.

Symptoms appear suddenly, often dramatically.

Why so sudden?

Because those blasts are proliferating so fast in the marrow, they just crowd everything else out.

Normal production tanks.

Leading to...

Classic triad of bone marrow failure symptoms.

Anemia, because no red cells are being made right here, extreme fatigue.

Thrombocytopenia, because no platelets, easy bruising, bleeding.

And neutropenia, because no functional neutrophils spread here over current infections, fever.

That sounds devastating.

It is.

Bone pain is also really common, from the marrow literally expanding with cancer cells.

Are ALL in AML different in who they affect?

Generally, yes.

ALL -L is actually the most common childhood cancer.

Yeah.

It involves precursor B or T lymphocytes, lymphoblasts.

AML is more common in older adults and affects the myeloid precursor cells.

And AWOL has a tendency to go to the CNS.

Yes.

Central nervous system involvement is more frequent in ALL than AML, requiring specific treatment strategies to target the brain and spinal fluid.

You mentioned an emergency situation with acute leukemia.

Ah, yes, leukostasis.

This can happen when the blast count in the blood gets incredibly high, usually over 100 ,000 cells per microliter.

So many cells, they clock things up.

Literally.

The blood becomes thick, viscous.

It struggles to flow through small vessels, especially in the lungs and brain.

Causing?

Sudden shortness of breath if it's pulmonary leukostasis, or headache, confusion, even stroke if it's cerebral.

It's a true medical emergency, requiring immediate treatment to lower the blast count, like acarisis or urgent chemo.

Okay, contrasting with the acute forms, what about the chronic leukemias, CLL and CML?

Right.

Chronic lymphocytic leukemia, CLL, and chronic myelogenous, CML.

Generally slower onset, diseases often found in older adults.

The cells involved look more mature, less like blasts, at least initially.

CLL first.

CLL is the most common adult leukemia in the West.

It's a malignancy of B lymphocytes, but they look mature, just dysfunctional.

Many patients are actually asymptomatic for years, diagnosed instantly on a blood test.

But it can become aggressive.

It can.

Over time, it can lead to significant lymph node swelling.

And because the B cells are faulty, patients develop immunodeficiency, particularly low antibody levels, hypogammaglobulania, leading to infections.

And CML.

We know it has the Philadelphia chromosome.

Correct.

CML is defined by BCRABL.

It classically progresses through three phases.

A chronic phase, where treatment can often control it well.

An accelerated phase, where things get harder to manage.

And finally, a terminal blast crisis.

Blast crisis, meaning?

Meaning it essentially transforms into an acute leukemia filled with blasts.

A very dangerous stage.

Okay.

One more major category to cover.

Multiple myeloma.

This one's different again, right?

Plasma cells.

Yes.

Multiple myeloma is a cancer of the most mature B cell type.

The plasma cell.

It's specifically a plasma cell dyscrasia.

What goes wrong?

A single clone of malignant plasma cells takes over the bone marrow.

And instead of making helpful antibodies, they churn out massive amounts of a single, useless monoclonal immunoglobulin.

We call this the M protein, usually IgG or IgA type.

And the main impact is on bones.

Devastatingly so.

The malignant plasma cells produce factors, like NRA and KL, that activate osteoclasts, the cells that normally break down bone.

So they stimulate bone destruction.

Exactly.

Leading to widespread bone resorption.

You get these characteristic osteolytic lesions, basically holes punched out in the skeleton, visible on x -rays.

Which must cause.

Intense bone pain.

It's the first symptom for about 75 % of patients.

Also leads to pathologic fractures, bones breaking under minimal stress.

And all that bone breakdown releases calcium.

Right.

Causes hypercalcemia, dangerously high calcium levels in the blood, which has its own set of symptoms like confusion, constipation, kidney problems.

Kidney problems seem common too.

Very common.

Partly due to hypercalcemia, but also because the excess light chains from the M protein, called Benz -Jones proteins when they spill into the urine, are directly toxic to the kidney tubules.

Renal insufficiency is a major issue.

So how is myeloma diagnosed?

Is there a triad for this too?

There's a classic diagnostic triad, yes.

Finding increased malignant plasma cells in the bone marrow, plasmacytosis.

Seeing those atlantic bone lesions on imaging, and detecting the M protein spike in the blood, or Benz -Jones proteins in the urine.

Hashtag tag tag outro.

Wow.

Okay, we have covered a huge amount of ground today.

From just the basic job of neutrophils and lymphocytes.

Right, the foundation.

All the way through viral proliferation and mono, and then into the really complex genetically driven cancers, Hodgkin's, non -Hodgkin's, the acute and chronic leukemias.

And finishing with multiple myeloma, that bone destroying plasma cell cancer.

It's a lot.

It really is.

Is there one key takeaway maybe to help tie this all together?

I think a really useful way to think about it, especially differentiating the cancers, is to consider where in the cell's life story the transformation happened.

Where in the differentiation pathway?

Exactly.

Did the mutation hit a very immature rapidly dividing blast cell?

If so, you tend to get an explosive acute leukemia like ARL or AML.

Okay.

Or did it hit a more mature already differentiated cell like in CLL or multiple myeloma?

Then the disease course might be slower.

More about accumulation of dysfunctional cells, at least initially.

The cell's origin really dictates its behavior, where it goes, and how the disease unfolds.

That's a great way to frame it.

So what does this all mean for you listening?

Well, hopefully you now have a much clearer picture connecting the underlying cellular failures to the actual diseases and symptoms we see in these critical hematologic disorders.

Understanding the why behind the what.

Precisely.

Thanks so much for joining us on this deep dive.